Product Information

POTASSIUM CHLORIDE 20% (40 MEQ/15 ML) ORAL LIQUID is a generic product labeled by Granules Pharmaceuticals Inc., priced at $0.0778 per ML under NDC 70010007344. Its NADAC has been published 250 times since Nov 10, 2021.

FDA first approved this application on Jan 29, 2021. Its Orange Book therapeutic-equivalence code is AA.

POTASSIUM CHLORIDE 20% (40 MEQ/15 ML) ORAL LIQUID

POTASSIUM CHLORIDE
$0.0778per ML

Strength

40 meq/15mL

NDC

70010007344

Classification

Generic

Dosage Form

SOLUTION

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

POTASSIUM CHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA213392

FDA Approved

1/29/2021

TE Code

AA

On Market Since

4/25/2021

Pharmacological Classes

Increased Large Intestinal Motility
Inhibition Large Intestine Fluid/Electrolyte Absorption
Osmotic Activity
Osmotic Laxative
Potassium Compounds
Potassium Salt

Price Statistics

The NADAC for POTASSIUM CHLORIDE 20% (40 MEQ/15 ML) ORAL LIQUID has been published 250 times since Nov 10, 2021, and over the history we have for it it has declined 87.9%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0778 per ML
All-time high$0.6526 (Dec 15, 2021)
All-time low$0.0440 (Dec 17, 2025)
52-week high$0.0778
52-week low$0.0440
Median price$0.1337
Average price$0.1533
Largest weekly change+163.0% (Jan 18, 2023)
Weeks tracked250
Tracking sinceNov 10, 2021

Price History

1W

+10.7%

1M

+38.5%

3M

+73.9%

6M

+54.9%

1Y

+15.0%

3Y

-63.6%

5Y

N/A

All

-87.9%

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of POTASSIUM CHLORIDE 20% (40 MEQ/15 ML) ORAL LIQUID?

The current National Average Drug Acquisition Cost (NADAC) for POTASSIUM CHLORIDE 20% (40 MEQ/15 ML) ORAL LIQUID, manufactured by Granules Pharmaceuticals Inc., is $0.0778 per ML (NDC 70010007344), effective Aug 19, 2026.

How has the price of POTASSIUM CHLORIDE 20% (40 MEQ/15 ML) ORAL LIQUID changed over time?

Over the history we have for it, the NADAC for POTASSIUM CHLORIDE 20% (40 MEQ/15 ML) ORAL LIQUID has declined 87.9%. It has been tracked across 250 weekly CMS publications since Nov 10, 2021.

What are the highest and lowest recorded NADAC prices for POTASSIUM CHLORIDE 20% (40 MEQ/15 ML) ORAL LIQUID?

Since Nov 10, 2021, the NADAC for POTASSIUM CHLORIDE 20% (40 MEQ/15 ML) ORAL LIQUID has ranged from a low of $0.0440 (Dec 17, 2025) to a high of $0.6526 (Dec 15, 2021), with a median of $0.1337 per ML.

Are there cheaper alternatives to POTASSIUM CHLORIDE 20% (40 MEQ/15 ML) ORAL LIQUID?

3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as POTASSIUM CHLORIDE 20% (40 MEQ/15 ML) ORAL LIQUID in a comparable dosage form, but none are currently priced below it.

Who manufactures POTASSIUM CHLORIDE 20% (40 MEQ/15 ML) ORAL LIQUID?

POTASSIUM CHLORIDE 20% (40 MEQ/15 ML) ORAL LIQUID (NDC 70010007344) is labeled by Granules Pharmaceuticals Inc., and CMS classifies it as a generic product.